CPT code 92565 represents a specific audiologic diagnostic procedure that delivers identical-frequency tones to both ears simultaneously to identify unilateral hearing loss or pseudohypacusis. This targeted test helps clinicians and payers distinguish true asymmetric sensorineural or conductive loss from nonorganic or exaggerated hearing complaints, which has implications for clinical management and utilization oversight nationwide. Key payers examined in coverage and reimbursement discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent and typical settings for CPT code 92565, plus comparative viewpoints on payer coverage approaches, common billing modifiers, and where this service fits within audiology service lines. The publication outlines benchmarking context and policy considerations relevant to national stakeholders, and it provides practical detail on coding nomenclature and service characterization for billing, compliance, and clinical documentation workflows. Data not available in the input for payer-specific rates, utilization benchmarks, associated taxonomies, and ICD-10 pairing are noted where relevant.